Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
March 22, 2015
Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages
Yun Shi, Xuejun Fan, Hui Deng, et al.
Nanotechnology
|
September 5, 2019
High-performance humidity sensor using Schottky-contacted SnS nanoflakes for noncontact healthcare monitoring
Hongyu Tang, Yutao Li, Huaiyu Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2015
Dysfunctional Antibodies in the Tumor Microenvironment Associate with Impaired Anticancer Immunity
Ningyan Zhang, Hui Deng, Xuejun Fan, et al.
Cancer Research Communications
|
June 28, 2023
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity
Hong Jiang, Dong Ho Shin, Yanhua Yi, et al.
Breast Cancer Research : BCR
|
August 10, 2012
A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy
Xuejun Fan, Randall J Brezski, Ming Fa, et al.
Molecular Cancer Therapeutics
|
January 2, 2015
A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodies
Xuejun Fan, Randall J Brezski, Hui Deng, et al.
Science Translational Medicine
|
September 7, 2022
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease
Peng Zhao, Yuanzhong Xu, LuLin Jiang, et al.
Oncotarget
|
February 25, 2016
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
Nahir Cortes-Santiago, Mohammad B Hossain, Konrad Gabrusiewicz, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2017
Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody
Weixu Meng, Aimin Tang, Xiaohua Ye, et al.
Neuro-Oncology Advances
|
October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
Yisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Journal of Immunology (Baltimore, Md. : 1950)
|
March 22, 2015
Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages
Yun Shi, Xuejun Fan, Hui Deng, et al.
Nanotechnology
|
September 5, 2019
High-performance humidity sensor using Schottky-contacted SnS nanoflakes for noncontact healthcare monitoring
Hongyu Tang, Yutao Li, Huaiyu Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2015
Dysfunctional Antibodies in the Tumor Microenvironment Associate with Impaired Anticancer Immunity
Ningyan Zhang, Hui Deng, Xuejun Fan, et al.
Cancer Research Communications
|
June 28, 2023
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity
Hong Jiang, Dong Ho Shin, Yanhua Yi, et al.
Breast Cancer Research : BCR
|
August 10, 2012
A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy
Xuejun Fan, Randall J Brezski, Ming Fa, et al.
Molecular Cancer Therapeutics
|
January 2, 2015
A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodies
Xuejun Fan, Randall J Brezski, Hui Deng, et al.
Science Translational Medicine
|
September 7, 2022
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease
Peng Zhao, Yuanzhong Xu, LuLin Jiang, et al.
Oncotarget
|
February 25, 2016
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
Nahir Cortes-Santiago, Mohammad B Hossain, Konrad Gabrusiewicz, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2017
Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody
Weixu Meng, Aimin Tang, Xiaohua Ye, et al.
Neuro-Oncology Advances
|
October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
Yisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.
Page
of 8